While some authors suggested that it could represent a more aggressive disease with higher incidence of RB1 deletion [91, 92], our group has found RB1 deletion rates similar to large cohorts of unselected CLL patients with 13q deletion (20–25%) (personal observation). This evidence concerns the gene RB1 and B-cell chronic lymphocytic leukemia.